Astec LifeSciences MD Ashok Hiremath sells stock worth ₹165 million
The stock has rallied on the back of strong earnings growth and overall optimism for pharma sector
Shailaja Mohapatra - August 13, 2020
How Kishore Biyani's maverick moves pushed him to breaking point
The pioneer of India’s modern retail built an empire but created little value for shareholders
Krishna Gopalan - July 10, 2020
Tata Elxsi is steering away from the automotive lane to remain on the growth track
The overshadowed Tata company is proving its worth with swift and smart detours
Meenakshi Radhakrishnan-Swami - July 30, 2020
Will we see further earnings downgrade post Q1FY21 results?
As the lockdown continues in several parts of the country, growth is barely picking up
July 16, 2020
Harvesting growth, not uncertainty. That is the challenge
India’s agriculture sector will wither away unless the government finds a way to fertilise it
July 11, 2020
Every slump has a silver lining
Discretionary consumption has been hurt, but some businesses could see renewed investor interest
June 19, 2020
Kiran Mazumdar Shaw’s multi-billion dollar baby
Biocon Biologics’ valuation has raised eyebrows. But the parent has strong growth on its side and a track record of solid execution
Kripa Mahalingam - April 25, 2020
Land of no growth
The lockdown extension may have been crucial, but the collateral damage to India’s GDP will take its own time to repair
April 25, 2020
How India Inc is countering coronavirus | Editor's note
Top India Inc honchos share their insights on what needs to be done
N Mahalakshmi - April 16, 2020
"The VC community makes money during the good times, and makes its reputation during the hard times"
Tough times face India’s star-studded start-up ecosystem, but is there light at the end of the tunnel?
Hari Menon - April 11, 2020
